CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on November 8, 2017
WEXLER BURKHART HIRSCHBERG & UNGER LLP ATTORNEYS AND COUNSELORS AT LAW
377 OAK STREET CONCOURSE LEVEL C2 GARDEN CITY, NEW YORK 11530 |
||
STEPHEN B. WEXLER DAVID HIRSCHBERG MARTIN P. UNGER IAN J. FRIMET |
TELEPHONE (516) 222-2230 |
ERROL A. BURKHART (8/38 –11/11)
|
FACSIMILE: (516) 745-6449
|
||
ASSOCIATE MARIO C. LATTUGA |
|
|
GENERALINFO@WBHULAW.COM
|
||
OF COUNSEL JOLIE G. KAHN JOEL B. MEIROWITZ |
WWW.WBHULAW.COM |
November 8, 2017
VIA EDGAR
Bernard Nolan, Esq.
U.S. Securities and Exchange Commission
Washington, D.C. 20549
Re: Inpixon Proxy Statement on Schedule 14A
The purpose of this letter is to confirm that the below table has been inserted on p. 26 of the aforesaid proxy statement in lieu of the table filed in Amendment No. 1 to Schedule 14A, which was filed on November 6, 2017:
Proposed Ratio |
Number of Common Shares Authorized |
Approximate Number of Common Shares Outstanding |
Approximate Number of Unreserved Common Shares Available for Future Issuance |
|||||||||
1-for-5 | 50,000,000 | 3,211,027 | 46,788,973 | |||||||||
1-for-50 | 50,000,000 | 321,103 | 49,678,897 |
I confirm that the above table will be set forth as above in the Definitive Schedule 14A to be filed upon your approval to so file.
Thank you for your consideration in this matter.
Very truly yours,
Jolie Kahn